Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
63.9M
-
Shares change
-
-1.86M
-
Total reported value, excl. options
-
$118M
-
Value change
-
-$7.34M
-
Put/Call ratio
-
0.26
-
Number of buys
-
54
-
Number of sells
-
-67
-
Price
-
$1.84
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q4 2024
157 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q4 2024.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.9M shares
of 84.7M outstanding shares and own 75.39% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (7.59M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (7.46M shares), VANGUARD GROUP INC (4.21M shares), Kynam Capital Management, LP (3.64M shares), Merck & Co., Inc. (2.72M shares), Vestal Point Capital, LP (2.57M shares), CITADEL ADVISORS LLC (2.46M shares), Point72 Asset Management, L.P. (2.2M shares), Samsara BioCapital, LLC (2.2M shares), and MPM BIOIMPACT LLC (2.16M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.